Does AbbVie (ABBV) stock go up or down depending on the month?
AbbVie month by month, year by year
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.4% | +4.1% | -6.3% | -2.8% | +3.0% | +15.6% | -0.3% | |||||
| 2025 | +3.5% | +13.7% | +0.2% | -6.9% | -4.6% | -0.3% | +1.8% | +11.3% | +10.0% | -5.8% | +4.4% | +0.3% |
| 2024 | +6.1% | +7.1% | +3.4% | -10.7% | -0.9% | +6.4% | +8.0% | +5.9% | +0.6% | +3.2% | -10.3% | -2.9% |
| 2023 | -8.6% | +4.2% | +3.6% | -5.2% | -8.7% | -2.3% | +11.0% | -1.8% | +1.4% | -5.3% | +0.9% | +8.8% |
| 2022 | +1.1% | +7.9% | +9.7% | -9.4% | +0.3% | +3.9% | -6.3% | -6.3% | -0.2% | +9.1% | +10.1% | +0.3% |
| 2021 | -4.4% | +5.1% | +0.4% | +3.0% | +1.5% | -0.5% | +3.2% | +3.9% | -10.7% | +6.3% | +0.5% | +17.5% |
| 2020 | -8.5% | +5.8% | -11.1% | +7.9% | +12.7% | +5.9% | -3.3% | +0.9% | -8.5% | -2.8% | +22.9% | +2.5% |
| 2019 | -12.9% | -1.3% | +1.7% | -1.5% | -3.4% | -5.2% | -8.4% | -1.3% | +15.2% | +5.1% | +10.3% | +0.9% |
| 2018 | +16.0% | +3.2% | -18.3% | +2.0% | +2.5% | -6.4% | -0.5% | +4.1% | -1.5% | -17.7% | +21.1% | -2.2% |
| 2017 | -2.4% | +1.2% | +5.4% | +1.2% | +0.1% | +9.8% | -3.6% | +7.7% | +18.0% | +1.6% | +7.4% | -0.2% |
| 2016 | -7.3% | -0.5% | +4.6% | +6.8% | +3.2% | -1.6% | +7.0% | -3.2% | -1.6% | -11.6% | +9.0% | +3.0% |
| 2015 | -7.8% | +0.2% | -3.2% | +10.5% | +3.0% | +0.9% | +4.2% | -10.9% | -12.8% | +9.4% | -2.4% | +1.9% |
| 2014 | -6.8% | +3.4% | +1.0% | +1.3% | +4.3% | +3.9% | -7.3% | +5.6% | +4.5% | +9.9% | +9.0% | -5.4% |
| 2013 | +0.6% | +10.5% | +12.9% | -7.3% | -3.2% | +10.0% | -6.3% | +5.0% | +8.3% | +0.0% | +9.0% | |
| Average | -2.6% | +3.9% | +0.1% | +0.7% | +0.4% | +1.9% | +1.1% | +0.7% | +1.5% | +0.7% | +6.4% | +2.6% |
| % of years up | 31% | 86% | 71% | 57% | 64% | 50% | 50% | 54% | 54% | 62% | 77% | 69% |
| Years observed | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 13 | 13 | 13 | 13 | 13 |
AbbVie month by month: the summary
Over 2013-2026, here's what AbbVie (ABBV) stock did each month, on average: January -2.6% (up 31% of 13 years), February +3.9% (up 86% of 14 years), March +0.1% (up 71% of 14 years), April +0.7% (up 57% of 14 years), May +0.4% (up 64% of 14 years), June +1.9% (up 50% of 14 years), July +1.1% (up 50% of 14 years), August +0.7% (up 54% of 13 years), September +1.5% (up 54% of 13 years), October +0.7% (up 62% of 13 years), November +6.4% (up 77% of 13 years), December +2.6% (up 69% of 13 years). In other words, ABBV historically rose in February, March, April, May, June, July, August, September, October, November, December, and fell in January.
Does AbbVie really go up in November?
Over 2013-2026, November is AbbVie's strongest month: +6.4% on average, positive in 10 of 13 years. At the other end, January shows -2.6%. But a monthly gap is often built on one or two extreme years — the table above shows it: look at the spread, not just the average. Seasonality only means something when it has a cause (selling season, earnings calendar, year-end tax effects); with no identified cause, it's probably noise.
Frequently asked questions
Does AbbVie stock go up or down in February?
Over 14 years, ABBV rose +3.9% on average in February, finishing the month up 12 times out of 14 (86%). Median: +3.7%. It's one of its most consistent months. ⚠️ 14 years of data is not a prediction.
Does AbbVie stock go up or down in August?
Over 13 years, ABBV rose +0.7% on average in August, finishing the month up 7 times out of 13 (54%). Median: +0.9%. Results are split year to year — there's no clear pattern. ⚠️ 13 years of data is not a prediction.
Does AbbVie stock go up or down in December?
Over 13 years, ABBV rose +2.6% on average in December, finishing the month up 9 times out of 13 (69%). Median: +0.9%. Results are split year to year — there's no clear pattern. ⚠️ 13 years of data is not a prediction.
Does AbbVie stock go up or down in June?
Over 14 years, ABBV rose +1.9% on average in June, finishing the month up 7 times out of 14 (50%). Median: +0.3%. Results are split year to year — there's no clear pattern. ⚠️ 14 years of data is not a prediction.
Does AbbVie stock go up or down in September?
Over 13 years, ABBV rose +1.5% on average in September, finishing the month up 7 times out of 13 (54%). Median: +0.6%. Results are split year to year — there's no clear pattern. ⚠️ 13 years of data is not a prediction.
Does AbbVie stock go up or down in July?
Over 14 years, ABBV rose +1.1% on average in July, finishing the month up 7 times out of 14 (50%). Median: +0.8%. Results are split year to year — there's no clear pattern. ⚠️ 14 years of data is not a prediction.
What is the best month to buy AbbVie stock?
Historically, November: over the last 14 years, ABBV gained +6.4% on average that month and finished up 77% of the time (13 years observed). January is the weakest month (-2.6%). This is not a prediction: 14 years is a small sample, and the past is under no obligation to repeat.
Why does AbbVie stock often rise in November?
November has averaged as its best month over 14 years (+6.4%, up 77% of years). No clearly established recurring seasonal driver explains this month — it's a statistical tendency over 14 years of history, not a prediction.
Is there a best month to invest in the stock market in general?
There's no universal rule: every stock has its own seasonality. For ABBV it's November (+6.4% on average over 14 years) — another stock will look completely different. The calendar effects people cite ("sell in May", the year-end rally) are market-wide averages, not laws: on ABBV, February is the most consistent month (86% positive years). We also rank all 12 months for the whole market.
Does stock seasonality actually work?
Careful. A month that rose 14 times out of 14 can simply be chance: with 12 months and a dozen years, patterns appear naturally even in random data. Seasonality describes what happened; it doesn't explain why and predicts nothing. Treat it as context, never as a standalone buy signal.
What data is this table based on?
On ABBV's real monthly closing prices from 2013 to 2026 (14 years), source Yahoo Finance. Each cell = the price change over that month. Price performance, excluding dividends. Incomplete months and quote gaps are excluded.